 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: March 2026
Volume 11 | Issue 3
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 11
Issue Published : 118
Article Submitted : 21470
Article Published : 8508
Total Authors : 22383
Total Reviewer : 805
Total Countries : 157
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A Comprehensive Review on Hyperlipidemia: Exploring Core Concepts and Novel Drug Targets |
| Authors Name: | Hemalatha Venkidusamy , Poorana Pushkalai Saravanan , Sukirtha Ramakrishnan , Krishnakumar P , Selvarasu P |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_189538
|
| Published Paper Id: | IJRTI2404031 |
| Published In: | Volume 9 Issue 4, April-2024 |
| DOI: | |
| Abstract: | Hyperlipidemia is a metabolic disorder that affects the serum lipid and lipoprotein profiles. It is characterized by a quantitative increase in the net levels of total cholesterol (TC), triglycerides (TAG), very low-density lipoproteins (VLDL-C), and low-density lipoproteins (LDL-C), along with a concurrent reduction of high-density lipoprotein (HDL) concentrations in the bloodstream. It is one of the primary risk factors for cardiovascular diseases and has a notable effect on atherosclerosis. The present review gives an information on fundamentals of Hyperlipidemia which includes Introduction, Lipids and Lipoproteins, Epidemiology, Classification, Symptoms, Complications, Risk factors, Pathophysiology, Treatment, and new drugs to target hyperlipidemia. |
| Keywords: | Hyperlipidemia, Lipids and Lipoproteins, Cardiovascular disease, Hypolipidemic agents, Nutraceuticals. |
| Cite Article: | "A Comprehensive Review on Hyperlipidemia: Exploring Core Concepts and Novel Drug Targets", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 4, page no.234 - 244, April-2024, Available :http://www.ijrti.org/papers/IJRTI2404031.pdf |
| Downloads: | 000205304 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2404031
Registration ID:189538
Published In: Volume 9 Issue 4, April-2024
DOI (Digital Object Identifier):
Page No: 234 - 244 Country: Namakkal, Tamilnadu, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2404031 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2404031 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2026 - All Rights Reserved - IJRTI | |||